Anat Burkovitz, CEO of TrojanBio, sits down with Neil to discuss its AI-drive antibodies platform, how it enlists the viral immune system in the fight against cancer, and why she thinks the technology will broaden the population of patients who will benefit from immunotherapies.
Информация
- Подкаст
- Опубликовано1 июня 2023 г., 08:00 UTC
- Длительность40 мин.
- ОграниченияБез ненормативной лексики